A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond
| Errataetall: |
CommentOn: J Am Coll Cardiol. 2020 May 5;75(17):2140-2152. - PMID 32354382 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Journal of the American College of Cardiology - 75(2020), 17 vom: 05. Mai, Seite 2153-2155 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Boutjdir, Mohamed [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoantibodies |
|---|
| Anmerkungen: |
Date Completed 18.12.2020 Date Revised 18.12.2020 published: Print CommentOn: J Am Coll Cardiol. 2020 May 5;75(17):2140-2152. - PMID 32354382 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jacc.2020.03.027 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309380936 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309380936 | ||
| 003 | DE-627 | ||
| 005 | 20231225133803.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jacc.2020.03.027 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1031.xml |
| 035 | |a (DE-627)NLM309380936 | ||
| 035 | |a (NLM)32354383 | ||
| 035 | |a (PII)S0735-1097(20)34632-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Boutjdir, Mohamed |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.12.2020 | ||
| 500 | |a Date Revised 18.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: J Am Coll Cardiol. 2020 May 5;75(17):2140-2152. - PMID 32354382 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a autoantibodies | |
| 650 | 4 | |a autoimmunity | |
| 650 | 4 | |a channelopathies | |
| 650 | 4 | |a long QT syndrome | |
| 650 | 4 | |a peptides | |
| 650 | 4 | |a short QT syndrome | |
| 650 | 7 | |a KCNQ1 Potassium Channel |2 NLM | |
| 650 | 7 | |a KCNQ1 protein, human |2 NLM | |
| 650 | 7 | |a Peptides |2 NLM | |
| 700 | 1 | |a Lazzerini, Pietro Enea |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American College of Cardiology |d 1987 |g 75(2020), 17 vom: 05. Mai, Seite 2153-2155 |w (DE-627)NLM012608602 |x 1558-3597 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2020 |g number:17 |g day:05 |g month:05 |g pages:2153-2155 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jacc.2020.03.027 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2020 |e 17 |b 05 |c 05 |h 2153-2155 | ||